List of Qoliana drug patents

Qoliana is owned by Sandoz Inc.

Qoliana contains Brimonidine Tartrate.

Qoliana has a total of 1 drug patent out of which 0 drug patents have expired.

Qoliana was authorised for market use on 22 May, 2006.

Qoliana is available in solution/drops;ophthalmic dosage forms.

The generics of Qoliana are possible to be released after 19 August, 2025.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7265117 SANDOZ INC Topical brimonidine tartrate formulations that lack chlorine dioxide
Aug, 2025

(2 years from now)

Drugs and Companies using BRIMONIDINE TARTRATE ingredient

Market Authorisation Date: 22 May, 2006

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in